Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.
ncRNA
LINC00511
Specific or universal ncRNAs
Universal ncRNAs
Class
Long non-coding RNA
Biomarker
Yes
Biomarker application
Prognosis
Upstream regulatory factor
Not available
Downstream target
miR-185/STXBP4
Differential expression in
recurrence vs. nonrecurrence
Up
Cancer name
Breast Cancer
Alias
Cancer site
Breast
Recurrence type
Recurrence
Overall survival rate of patients with
high ncRNA expression
Down
ncRNA differential expression in
cancer
patients vs. health people
Not available
Number of patients
98
Male patients
Not available
Female patients
Not available
Age range and number
38(<=50)+60(>50)
Recurrence patients
18
Recurrence patients male:female
Not available
Recurrence patients age range
Not available
Recurrence mean age
Not available
Sites of recurrence
Not available
Patients without recurrence
80
Patients without recurrence male:female
Patients without recurrence age range
Not available
Patients without recurrence mean age
Not available
PMID
Description
LINC00511 may be a significant predictor for recurrence and poor prognosis in patients with breast cancer.
Tissue resource
breast epithelial cell lines MCF-10A
breast cancer cell lines MCF-7
breast cancer cell lines MDA-MB-361
breast cancer cell lines MDA-MB-436
breast cancer cell lines MDA-MB-231
breast cancer tissue
Experiment
qRT-PCR,Western blot,Dual-Luciferase reporter assay
Institute
Shanghai Institute of Cell Biology
the Affiliated Hospital of Southwest Medical University
Country
China
Continent
Asia
Institutes for Systems Genetics, West China Hospital
Copyright @ 2022 ISG. All Rights Reserved.